News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MorphoSys AG Enters Therapeutic Research Collaboration on Novel Target Molecule with Genesis Research and Development Corporation (GEN.NZ)


10/8/2007 9:09:41 AM

Auckland, New Zealand, Oct 8, 2007 - (ABN Newswire ) - Martinsried/Munich, Germany, and Auckland, New Zealand, - MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment) today announced the signing of a research collaboration with New Zealand-based Genesis Research and Development Corporation Ltd. (New Zealand Stock Exchange: GEN) (ASX: GEN).

Read at ABN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES